Dental Implants OKTAGON Tissue Level and Bone Level

K162073 · Hager& Meisinger GmbH · DZE · Feb 24, 2017 · Dental

Device Facts

• Record ID: K162073
• Device Name: Dental Implants OKTAGON Tissue Level and Bone Level
• Applicant: Hager& Meisinger GmbH
• Product Code: DZE · Dental
• Decision Date: Feb 24, 2017
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 872.3640
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The implants are surgically placed in the maxillary and/ or mandibular arches to provide support for prosthetic restorations in edentulous or partially edentulous patients. The parts are intended to be used with OKTAGON® respectively Bone Level abutments and prosthetic parts. The OKTAGON Implant System is intended for delayed loading, or for immediate loading when good primary stability is achieved and with appropriate occlusal load.

Device Story

Root-form endosseous dental implants; made of commercially pure Titanium Grade 4 (ASTM F67). Surface features microstructured endosteal section, corundum-blasted, and acid-etched; polished implant shoulder. Prosthetic connection utilizes inner cone with octagonal anti-rotation device. Sterile cover screw included for internal thread occlusion post-insertion. Used by dental surgeons in clinical settings for tooth replacement. Implants provide structural support for prosthetic restorations; enable delayed or immediate loading based on primary stability and occlusal load. Benefits include restoration of oral function and aesthetics for patients with missing teeth.

Clinical Evidence

Bench testing only. Fatigue testing conducted per ISO 14801. Compliance with ISO 10993-1, ISO 10993-5, and other relevant standards for biocompatibility, sterilization, and mechanical performance demonstrated.

Technological Characteristics

Material: Commercially pure Titanium Grade 4 (ASTM F67). Design: Root-form, inner cone with octagonal anti-rotation. Surface: Corundum-blasted, acid-etched, polished shoulder. Sterilization: Gamma irradiation (min 25 kGy). Standards: ISO 14801 (fatigue), ISO 10993 (biocompatibility), ISO 11137 (sterilization).

Indications for Use

Indicated for edentulous or partially edentulous patients requiring prosthetic restoration support via surgical placement in maxillary or mandibular arches.

Regulatory Classification

Identification

An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.

Special Controls

*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.

Predicate Devices

• Dental Implant OKTAGON (K122807)
• Dental Implant System OKTAGON Bone Level (K143539)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other, with flowing lines representing hair or clothing.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

February 24, 2017

Hager & Meisinger GmbH Melanie May Regulatory Affairs Hansemannstrasse 10 Neuss. 41468 GERMANY

Re: K162073

Trade/Device Name: Dental Implants OKTAGON Tissue Level and Bone Level Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE Dated: January 31, 2017 Received: February 3, 2017

Dear Melanie May:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

{1}------------------------------------------------

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely.

# Michael J. Ryan -S

for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

#### Indications for Use Statement

510(k) Number (if known): K162073

Dental Implants OKTAGON® Tissue Level Device Name: and Bone Level

Indications for use:

The implants are surgically placed in the maxillary and/ or mandibular arches to provide support for prosthetic restorations in edentulous or partially edentulous patients.

The parts are intended to be used with OKTAGON® respectively Bone Level abutments and prosthetic parts.

The OKTAGON Implant System is intended for delayed loading, or for immediate loading when good primary stability is achieved and with appropriate occlusal load.

Prescription Use X Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ (Part 21 CFR 801 Subpart D) (Part 21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

{3}------------------------------------------------

# K162073

## 1. Applicant's Name and Address

| Contact Person: | Dr. Melanie May<br>Regulatory Affairs | |
|-----------------|-----------------------------------------------|--------------------------------------------------------------------|
| | Phone No.:<br>Fax No.:<br>Email: | [phone]<br>[phone]<br>[e-mail] |
| | Hager & Meisinger GmbH<br>Hansemannstrasse 10 | |

41468 Neuss Germany

# 2. Date prepared

February 22nd, 2017 Date prepared:

#### 3. Name of the device

| Trade Name: | Dental Implants OKTAGON® Tissue Level and Bone Level |
|----------------------|------------------------------------------------------|
| Common Name: | Endosseous dental implants |
| Classification Name: | Endosseous dental implants |
| Product Code: | DZE |
| Regulation No: | 872.3640 |
| Class: | II |
| Panel: | Dental |

#### 4. Predicate Devices

| 510(k) No. | Manufacturer | Trade Name |
|-----------------------------------------|------------------------|----------------------------------------------|
| K122807<br>(Primary Predicate Device) | Hager & Meisinger GmbH | Dental Implant OKTAGON® |
| K143539<br>(Reference Predicate Device) | Hager & Meisinger GmbH | Dental Implant System<br>OKTAGON® Bone Level |

#### 5. Device Description

The Dental Implants OKTAGON® Tissue Level and Bone Level follow a root-form design and are made of commercially pure Titanium Grade 4 conforming to ASTM- F67. The surface is microstructured in the endosteal section and the surface has been blasted with high-grade corundum and afterwards acid-etched. The implant shoulder of Dental Implants OKTAGON® Tissue Level and Bone Level is polished.

{4}------------------------------------------------

## 510(k) Summary

The prosthetic connection is achieved with the help of an inner cone with an additional octagonal antirotation device. A sterile cover screw is enclosed with the implant so that an immediate occlusion of the internal thread is possible after successful insertion.

Subject to this submission are the following implant variations:

BL NC Ø3.75 mm, L 8 mm BL NC Ø3.75 mm, L 10 mm BL NC Ø3.75 mm, L 12 mm

TL RP Ø3.75 mm, L 8 mm TL RP Ø3.75 mm, L 10 mm TL RP Ø3.75 mm, L 12 mm

TL RP Conical Ø4.1 mm, L 10 mm

#### 6. Indications for Use

The implants are surgically placed in the maxillary and/ or mandibular arches to provide support for prosthetic restorations in edentulous or partially edentulous patients.

The parts are intended to be used with OKTAGON® respectively Bone Level abutments and prosthetic parts.

The OKTAGON Implant System is intended for delayed loading, or for immediate loading when good primary stability is achieved and with appropriate occlusal load.

#### 7. Performance tests and used standards

Performance tests (fatique tests) have been conducted, fulfilling the requirements of ISO 14801 and the FDA's "Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Abutments".

The following standards have been followed for the development, production, performance and safety testing of Dental Implants OKTAGON®: ISO 14801, ISO 7405, ISO 10993-1, ISO 5832-2, ASTM F67, ISO 11137-1, ISO 14971, ISO 11137-2, ISO 10993-5, ANSI/AAMI ST79, ISO 11607-1:2009, ASTM F88/F88M-09, ASTM F1929-98 (2004).

The following standards have been followed sterilization for the accessories: ISO 17665-1, ISO 17665-2.

{5}------------------------------------------------

# 8. Technological Characteristics

| Manufacturer | Hager & Meisinger GmbH | Hager & Meisinger GmbH | Hager & Meisinger GmbH |
|---------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 510(k) Number | K162073 | K122807 | K143539 |
| | | (Primary Predicate Device) | (Reference Predicate Device) |
| Intended Use | The implants are surgically<br>placed in the maxillary and/or<br>mandibular arches to provide<br>support for prosthetic<br>restorations in edentulous or<br>partially edentulous patients.<br>The parts are intended to be<br>used with OKTAGON®<br>respectively Bone Level<br>abutments and prosthetic parts.<br>The OKTAGON® Implant<br>System is intended for delayed<br>loading, or for immediate<br>loading when good primary<br>stability is achieved and with<br>appropriate occlusal load. | The implants are surgically<br>placed in the maxillary and/or<br>mandibular arches to provide<br>support for prosthetic<br>restorations in edentulous or<br>partially edentulous patients.<br>The implants are intended to be<br>used with OKTAGON®<br>abutments and prosthetic parts. | The implants are surgically<br>placed in the maxillary and/or<br>mandibular arches to provide<br>support for prosthetic<br>restorations in edentulous or<br>partially edentulous patients.<br>The parts are intended to be<br>used with OKTAGON® Bone<br>Level abutments and prosthetic<br>parts.<br>The Dental Implant system<br>OKTAGON® Bone Level is<br>intended for delayed loading, or<br>for immediate loading when<br>good primary stability is<br>achieved and with appropriate<br>occlusal load. |
| Implant | BL NC Ø3.75 mm, L 8 mm | TL RP Ø3.3 mm, L 8 mm | BL NC Ø3.3 mm, L 8 mm |
| Variations | BL NC Ø3.75 mm, L 10 mm | TL RP Ø3.3 mm, L 10 mm | BL NC Ø3.3 mm, L 10 mm |
| | BL NC Ø3.75 mm, L 12 mm | TL RP Ø3.3 mm, L 12 mm<br>TL RP Ø3.3 mm, L 14 mm | BL NC Ø3.3 mm, L 12 mm<br>BL NC Ø3.3 mm, L 14 mm |
| | TL RP Ø3.75 mm, L 8 mm | | |
| | TL RP Ø3.75 mm, L 10 mm | TL RP Ø4.1 mm, L 8 mm | BL RC Ø4.1 mm, L 8 mm |
| | TL RP Ø3.75 mm, L 12 mm | TL RP Ø4.1 mm, L 10 mm | BL RC Ø4.1 mm, L 10 mm |
| | TL RP Conical Ø4.1 mm, L 10<br>mm | TL RP Ø4.1 mm, L 12 mm | BL RC Ø4.1 mm, L 12 mm |
| | | TL RP Ø4.1 mm, L 14 mm | BL RC Ø4.1 mm, L 14 mm |
| | | TL RP Ø4.8 mm, L 8 mm | BL RC Ø4.8 mm, L 8 mm |
| | | TL RP Ø4.8 mm, L 10 mm | BL RC Ø4.8 mm, L 10 mm |
| | | TL RP Ø4.8 mm, L 12 mm | BL RC Ø4.8 mm, L 12 mm |
| | | TL RP Ø4.8 mm, L 14 mm | BL RC Ø4.8 mm, L 14 mm |
| | | TL RP TD Ø4.1 mm, L 10 mm<br>TL RP TD Ø4.1 mm, L 12 mm | |
| | | TL WP Ø4.8 mm, L 8 mm<br>TL WP Ø4.8 mm, L 10 mm<br>TL WP Ø4.8 mm, L 12 mm | |
| Accessories | A sterile cover screw is<br>enclosed with the implant so<br>that an immediate occlusion of<br>the internal thread is possible<br>after successful insertion. | A sterile cover screw is<br>enclosed with the implant so<br>that an immediate occlusion of<br>the internal thread is possible<br>after successful insertion. | A sterile cover screw is<br>enclosed with the implant so<br>that an immediate occlusion of<br>the internal thread is possible<br>after successful insertion. |
| | | Features | |
| Length | 8, 10, 12 mm | 8, 10, 12, 14 mm | 8, 10, 12, 14 mm |
| Diameter | Ø3.75 mm, Ø4.1 mm | Ø3.3 mm, Ø4.1 mm, Ø 4.8 mm | Ø3.3 mm, Ø4.1 mm, Ø 4.8 mm |
| Material (Implant<br>and<br>Cover<br>Screw) | Pure titanium Grade 4<br>conforming to ASTM Standard<br>Specification F67 | Pure titanium Grade 4<br>conforming to ASTM Standard<br>Specification F67 | Pure titanium Grade 4<br>conforming to ASTM Standard<br>Specification F67 |
| Surface<br>Treatment | The surface is micro-structured<br>in the endosteal section and the | The surface is micro-structured<br>in the endosteal section and the | The surface is micro-structured<br>in the endosteal section and the |
| Manufacturer | Hager & Meisinger GmbH | Hager & Meisinger GmbH | Hager & Meisinger GmbH |
| Implant-to-<br>abutment<br>connection | implant shoulder is polished.<br>The implant surface has been<br>blasted with high-grade<br>corundum and afterwards acid-<br>etched.<br>Inner cone with octagonal anti-<br>rotation device | implant shoulder is polished.<br>The implant surface has been<br>blasted with high-grade<br>corundum and afterwards acid-<br>etched.<br>Inner cone with octagonal anti-<br>rotation device | implant shoulder is polished.<br>The implant surface has been<br>blasted with high-grade<br>corundum and afterwards acid-<br>etched.<br>Inner cone with octagonal anti-<br>rotation device |
| Packaging | Implants are sold in plastic<br>tubes, fastened on a titanium<br>support with apre-assebled<br>insertion system.<br>The tube with the implant is<br>double-wrapped in blister<br>packaging. | Implants are sold in plastic<br>tubes, fastened on a titanium<br>support with apre-assebled<br>insertion system.<br>The tube with the implant is<br>double-wrapped in blister<br>packaging. | Implants are sold in plastic<br>tubes, fastened on a titanium<br>support with apre-assebled<br>insertion system.<br>The tube with the implant is<br>double-wrapped in blister<br>packaging. |
| Sterilization | Gamma Irradiation, min. 25 kGy.<br>The validation fulfills the<br>requirements of ISO 11137-1<br>and 11137-2. | Gamma Irradiation, min. 25 kGy.<br>The validation fulfills the<br>requirements of ISO 11137-1<br>and 11137-2. | Gamma Irradiation, min. 25 kGy.<br>The validation fulfills the<br>requirements of ISO 11137-1<br>and 11137-2. |
| Shelf Life | 5 years | 5 years | 5 years |

{6}------------------------------------------------

The Dental Implants OKTAGON® Tissue and Bone Level are an addition to the currently distributed Dental Implant OKTAGON and to the Dental Implant System OKTAGON Bone Level.

The subject devices differ in that of an additional diameter of Ø3.75 mm and a conical design.

As the subject devices are comparable to the predicate devices in the intended use, material composition, surface treatment, the implant-to-abutment connection, the principal root-form design and the performance characteristics (e.g. strength and function) no new aspects regarding the substantial equivalence arise.

#### 9. Conclusion

Based on these observations, we conclude that the Dental OKTAGON® Tissue Level and Bone Level implants are substantially equivalent to the identified predicate devices.